Slide Insurance Holdings, Inc. Common Stock
SLDE
$26.04
-1.21%
Slide Insurance Holdings is a technology-enabled coastal specialty property and casualty insurer that underwrites single-family, condominium, landlord, and commercial residential policies along the Atlantic seaboard through its subsidiary, Slide Insurance Company. The company occupies a focused niche in coastal homeowners' insurance — a market that large national carriers have retreated from — positioning Slide as a specialist underwriter using proprietary data and technology to price catastrophe-exposed risk that others have abandoned. The investor narrative centers on the company's explosive post-IPO growth and profitability, with revenue up roughly 36% year-over-year and net margins near 38%, alongside a capital-light, low-debt operating model that has produced substantial free cash flow. Attention is also focused on the stock's strong post-listing momentum and a recent pullback from all-time highs, as well as the inherent catastrophe-risk exposure of a coastal Florida-concentrated book and the sustainability of underwriting margins as reinsurance costs and competitive dynamics evolve.…
SLDE
Slide Insurance Holdings, Inc. Common Stock
$26.04
Investment Opinion: Should I buy SLDE Today?
Rating: Buy (speculative, position-sized). The core thesis is that SLDE is a high-quality, hyper-growth coastal specialty underwriter trading at a deep discount to its earnings power — 4.10x trailing PE, 2.07x EV/EBITDA, and roughly 6.7x the $3.88 consensus forward EPS — because the market is pricing in catastrophe risk and margin normalization that have not yet appeared in results. All three covering analysts are constructive (Barclays Overweight, Citizens Market Outperform, KBW Outperform) with no Sell ratings, and the tight $3.80–$3.96 EPS estimate band (~4% spread) signals high conviction in near-term earnings visibility.
The supporting evidence is unusually strong for a stock this cheap: Q3 2026 revenue of $361.05M grew 35.89% YoY, net income of $138.23M produced a 38.29% net margin, and operating margin reached 44.80% — with net margin expanding from 26.79% in Q2 2025 to 38.29% now. Debt-to-equity is just 0.0389 with interest coverage above 100x, trailing free cash flow is $960.82M, ROE is 39.88%, and the company holds $1.72B in cash. Momentum confirms the fundamental story: +56.08% over one year versus the S&P 500's +9.59% (46.49 points of relative strength), and +39.76% YTD versus +7.83%. At 2.17x book and 2.09x sales, the multiple is modest for a 36%-growth, 38%-margin insurer, and the PE has compressed from 9.67x in Q2 2025 to 4.10x today even as the share price rose — earnings are outgrowing the stock.
The risks that could invalidate this thesis are (1) a major Florida hurricane landfall that erases multiple quarters of the $138.23M quarterly net income and triggers reinsurance repricing, (2) margin normalization from 44.80% operating levels as competitors re-enter coastal markets, and (3) the stock's technical extension — at $25.94 it sits ~89% of the way through its 180-day range of $16.03–$29.08 after a 20.01% max drawdown episode. The rating would upgrade to a higher-conviction Buy if the stock pulls back toward the $22.30–$23.00 support zone without fundamental deterioration, or if a full hurricane season passes with margins above 40%; it would downgrade to Hold if operating margin falls below 35% or if a single event drives a quarterly loss. Verdict: undervalued relative to earnings power and growth, but the discount is a rational catastrophe premium rather than a free lunch — hence Buy with sizing discipline, not a core position.
Sign up to view all
SLDE 12-Month Price Forecast
The forward view is constructive but not complacent: SLDE offers 36% revenue growth and a 38% net margin at 4.10x trailing earnings, a combination that only makes sense if the market is discounting a catastrophe event or margin normalization that has not yet shown up in any reported quarter. The base case (55% probability) assumes earnings near the $3.88 consensus with modest margin compression and a re-rating toward 7–8x forward EPS, implying $26–$32. The bear case (20%) is a genuine tail — a Florida landfall plus reinsurance repricing could take the stock to $16–$20, a -23% to -38% move — which is why confidence is medium rather than high despite the compelling multiple. I would upgrade to high confidence if a full hurricane season passes with operating margins above 40% and the stock holds above the $22.30 support zone; I would downgrade to neutral if operating margin falls below 35% or if a second analyst moves to the sidelines.
Wall Street consensus
Coverage is thin but uniformly constructive: three analysts cover SLDE, and the institutional ratings history shows a clear bullish tilt with no Sell ratings — Barclays maintains Overweight, Citizens reiterates Market Outperform, and Keefe, Bruyette & Woods carries Outperform, while Morgan Stanley downgraded to Equal Weight in July 2026, the sole note of caution. The consensus EPS estimate of $3.88 (range $3.80–$3.96) against the current price of $25.94 implies a forward earnings multiple of roughly 6.7x, and while a formal average price target is not disclosed in the data, the uniformly positive ratings and tight EPS estimate range suggest analysts see the stock as undervalued relative to its earnings power.
The narrow EPS estimate band ($3.80 to $3.96, a spread of just ~4%) signals high conviction in near-term earnings visibility, contrasting with the wider uncertainty typical of catastrophe-exposed insurers. The high end of estimates likely assumes continued underwriting margin strength and premium growth in Florida and other coastal markets, while the low end may embed modestly higher loss or expense assumptions; the absence of a published price-target range limits precise upside quantification, but the low forward multiple and strong ratings imply meaningful implied upside if earnings materialize. The limited coverage base — three firms, with one recent downgrade to Equal Weight — reflects the company's recent IPO and small-cap status, which can amplify volatility and reduce price-discovery efficiency, but the consistent Outperform/Overweight stance from the majority suggests institutional sentiment remains supportive of the growth and margin story.
Bulls vs Bears: SLDE Investment Factors
The bull case currently holds stronger evidence: 35.89% revenue growth, a 38.29% net margin, 39.88% ROE, near-zero leverage, and a 4.10x trailing PE create a valuation-versus-quality gap that is hard to ignore, and the market has rewarded it with 56% one-year returns. The bear case rests less on current fundamentals than on forward risk — a Florida-concentrated catastrophe book, margins that look cyclically peak, and a stock trading near the top of its range after a steep run. The single most important tension is whether the current 44.80% operating margin is a durable structural advantage of a specialist underwriter or a cyclical windfall from a hard reinsurance market; if margins hold through a full hurricane season, the low multiple re-rates sharply, but if they normalize, the 4.10x PE is a value trap rather than a bargain. Analyst sentiment (three positive ratings, no Sells, tight 4% EPS band) leans bullish, but the thin coverage and July 2026 downgrade mean conviction is not unanimous.
Bullish
- Extreme valuation discount to earnings: SLDE trades at a trailing PE of just 4.10x and EV/EBITDA of 2.07x, versus the 8–12x EV/EBITDA range typical of profitable specialty insurers. Against a consensus forward EPS of $3.88, the $25.94 price implies only ~6.7x forward earnings, a multiple that bakes in substantial catastrophe-risk skepticism.
- Hyper-growth with elite margins: Q3 2026 revenue of $361.05M grew 35.89% YoY from $265.69M, while net income of $138.23M produced a 38.29% net margin and 44.80% operating margin. Net margin has expanded from 26.79% in Q2 2025 to 38.29% now, showing scale benefits and underwriting discipline compounding together.
- Fortress balance sheet, minimal leverage: Debt-to-equity is only 0.0389, interest coverage exceeds 100x, and the company holds $1.72B in cash against a ~$2.4–3.2B market cap. Free cash flow of $960.82M on a trailing basis and ROE of 39.88% demonstrate that growth is being funded internally rather than through dilution or borrowing.
- Powerful relative momentum: SLDE is up 56.08% over one year and 39.76% YTD versus the S&P 500's 9.59% and 7.83%, a relative strength gap of 46.49 and 31.93 percentage points respectively. The one-month relative strength of +10.31 points against a -4.99% S&P shows genuine alpha, not beta drift.
Bearish
- Catastrophe concentration in coastal Florida: The entire book is single-family, condo, landlord, and commercial residential policies along the Atlantic seaboard, heavily Florida-concentrated. A single major hurricane landfall could erase multiple quarters of the $138.23M quarterly net income, and the 38% net margin is precisely the kind of result that attracts reinsurance repricing and new capital.
- Margin normalization risk from peak levels: Operating margin of 44.80% and EBITDA margin of 45.24% are far above normal P&C economics and reflect a hard market where national carriers retreated. As reinsurance costs reset and competitors re-enter coastal markets, these margins have substantial room to compress, and the market's 4.10x PE may already be discounting that normalization.
- Volatile and opaque cash flow: Q3 2026 operating cash flow was -$42.97M versus +$300.52M in Q2, a swing driven by seasonal premium and claims timing. The $960.82M trailing FCF figure masks this quarterly instability, and a poorly timed catastrophe could coincide with a negative cash quarter, straining the 1.27 current ratio.
- Short history and thin coverage: SLDE listed only in June 2025, so it has roughly 17 months of public trading history and just three analysts covering it. The July 2026 Morgan Stanley downgrade to Equal Weight is the sole cautionary note but illustrates how quickly sentiment can shift in a thinly covered small-cap with a $2.4B market cap.
SLDE Technical Analysis
SLDE is in a powerful, sustained uptrend, with the stock up 56.08% over the past year and 39.76% year-to-date, dramatically outperforming the S&P 500's 9.59% one-year and 7.83% YTD returns. At the current price of $25.94, the stock sits roughly 89% of the way through its 180-day trading range of approximately $16.03 (early-June low) to $29.08 (late-October high), confirming that it is trading near the upper end of its range and reflecting strong momentum positioning rather than deep-value territory. The recent high of $29.08 on October 26 marks the current ceiling, and the stock's proximity to that level suggests the market has been rewarding the growth and margin story, though it also raises the risk of overextension after a steep multi-month run.
Short-term momentum remains positive but is decelerating from its peak: the stock is up 5.32% over the past month and 22.76% over three months, a marked slowdown from the 40.52% six-month gain, indicating that the rate of appreciation is cooling even as the trend stays intact. The one-month gain of 5.32% compares favorably to the S&P 500's -4.99% over the same period, producing a relative strength of +10.31 percentage points, which underscores genuine outperformance rather than mere beta-driven drift. However, the most recent sessions show a pullback — the stock fell 1.85% on the latest day (from $26.43 to $25.94) and has slipped from the $29.08 high, suggesting profit-taking after the October surge; the 20.01% maximum drawdown over the period is a reminder of the stock's sensitivity to sentiment shifts.
Key technical support sits near the June low around $16.03, with a nearer-term support zone in the $22.30–$23.00 area where the stock consolidated in late September, while resistance is defined by the $29.08 all-time high. A breakout above $29.08 would signal renewed accumulation and likely open the door to fresh price discovery, whereas a breakdown below the $22.30 support would suggest the uptrend is losing structure and could target the $19–$20 region. The stock's volatility profile is elevated — beta data is not available, but the 20.01% max drawdown and the sharp 56% one-year move imply meaningfully higher volatility than the broad market, which warrants smaller position sizing and wider stop-loss levels for risk management.
Beta
—
—
Max Drawdown
-20.0%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+55.5%
Cumulative gain past year
| Period | SLDE Return | S&P 500 |
|---|---|---|
| 1m | +2.0% | -2.4% |
| 3m | +20.6% | -2.3% |
| 6m | +38.5% | +2.8% |
| 1y | +55.5% | +11.3% |
| ytd | +40.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SLDE Fundamental Analysis
Revenue growth is robust and consistent: Q3 2026 revenue reached $361.05 million, up 35.89% year-over-year from $265.69 million in Q3 2025, while the trailing four quarters totaled approximately $1.48 billion. The multi-quarter trajectory shows steady expansion — Q1 2026 at $389.28 million, Q2 at $386.82 million, and Q3 at $361.05 million — with the sequential dip reflecting normal seasonal underwriting patterns rather than deterioration, and the year-over-year comparison confirming durable double-digit growth. This growth trajectory supports an investment case built on market-share gains in coastal P&C, where displaced national carriers have created a large addressable opportunity for a specialist underwriter.
Profitability is exceptional for the P&C insurance industry: Q3 2026 net income was $138.23 million, translating to a 38.29% net margin, with operating income of $161.75 million and an operating margin of 44.80%. Gross margin is reported at 79.63% on a trailing basis (with Q3 gross margin at 100% due to the insurer's revenue presentation), and the net margin has expanded materially from 26.79% in Q2 2025 to the current 38.29%, reflecting both underwriting discipline and scale benefits. The EBITDA margin of 45.24% in Q3 2026 and 46.73% in Q2 2026 confirms that core underwriting economics remain strong, though investors should monitor whether catastrophe losses or reinsurance cost inflation could compress these unusually high margins going forward.
The balance sheet is conservatively managed: debt-to-equity is just 0.0389, the current ratio stands at 1.27, and interest coverage exceeds 100x, indicating negligible financial leverage risk. Free cash flow is substantial — $960.82 million on a trailing basis — though quarterly cash flow is volatile due to working-capital swings (Q3 2026 operating cash flow was -$42.97 million versus +$300.52 million in Q2), a normal pattern for insurers with seasonal premium and claims timing. ROE of 39.88% is exceptionally high and reflects both strong profitability and a relatively lean equity base, while the $1.72 billion cash balance provides ample liquidity to fund growth and absorb catastrophe events without external financing.
Quarterly Revenue
$361051000.0B
2026-09
Revenue YoY Growth
+35.9%
YoY Comparison
Gross Margin
100.0%
Latest Quarter
Free Cash Flow
$960821000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SLDE Overvalued?
Because net income is positive ($138.23 million in Q3 2026), the PE ratio is the appropriate primary metric. The trailing PE of 4.10x is remarkably low in absolute terms, and the forward PE of 0.021x — while likely distorted by data conventions — implies the market expects earnings to remain robust or grow; the enormous gap between trailing and forward multiples signals that consensus anticipates continued strong profitability, though the forward figure should be treated with caution given its implausibility. The PEG ratio of 0.021 also suggests the stock is priced at a steep discount to its growth rate, a hallmark of value-oriented insurance names.
Relative to the broader P&C insurance sector, SLDE trades at a meaningful discount on most metrics: its price-to-book of 2.17x and price-to-sales of 2.09x are modest for a company growing revenue at 36% with a 38% net margin, and its EV/EBITDA of 2.07x is far below the 8–12x range typical of profitable specialty insurers. The discount appears unjustified given SLDE's superior growth and margin profile, though it likely reflects the market's caution around coastal catastrophe exposure, the company's short public history (IPO in June 2025), and limited analyst coverage — factors that typically warrant a risk premium.
Historically, SLDE's valuation has compressed dramatically since its early trading days: the PE ratio has fallen from 9.67x in Q2 2025 to 4.10x currently, and price-to-book has declined from 3.12x to 2.17x over the same period, even as the stock price has risen. This compression reflects earnings growing faster than the share price, which is a bullish signal if sustainable, but it also means the stock now sits near the low end of its own historical valuation band — a setup that could represent a value opportunity if margins hold, or a warning if the market is anticipating margin normalization from unsustainably high levels.
PE
4.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~19x
vs. Industry Avg
12.7x
Industry PE ~12.7x*
EV/EBITDA
2.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the concentration and cyclicality of the underwriting book. Revenue of $361.05M in Q3 2026 is entirely dependent on coastal Atlantic property policies, meaning a single major hurricane could produce losses that dwarf the $138.23M quarterly net income, and the 38.29% net margin has no cushion built for a 1-in-50-year event. Quarterly operating cash flow already swung from +$300.52M in Q2 to -$42.97M in Q3, and the 1.27 current ratio leaves limited liquidity buffer if a catastrophe coincides with a negative cash quarter. Margins at 44.80% operating and 45.24% EBITDA are far above normal P&C economics and depend on reinsurance costs staying contained and the hard market persisting; any repricing of catastrophe reinsurance directly compresses these figures. Market and competitive risks stem from valuation ambiguity and sector dynamics. The 4.10x trailing PE and 2.07x EV/EBITDA look cheap, but the forward PE of 0.021x is clearly a data distortion, so investors cannot rely on forward multiples for comfort, and the PEG of 0.021 reflects a market that is skeptical the growth rate is sustainable. Beta is unavailable, but the 20.01% max drawdown and 56% one-year move imply volatility well above the broad market, and the stock's 89% position within its 180-day range means any sentiment shift has room to run. Thin coverage (three analysts) and a $2.4B market cap amplify price-discovery inefficiency, and the July 2026 Morgan Stanley downgrade to Equal Weight shows how a single note can move a lightly traded name. The worst-case scenario is a major Florida hurricane landfall combined with a reinsurance repricing that forces margin normalization, triggering analyst downgrades and a de-rating toward book value. In that chain, the stock could retrace to its June 2026 low of $16.03, roughly -38% from the current $25.94, and a deeper de-rating toward the $19–$20 breakdown zone would imply -23% to -27%. The 20.01% max drawdown already observed is a modest preview; a true catastrophe event could exceed it, so position sizing should assume a realistic downside of -35% to -40% in the adverse case.
FAQ
From a risk/reward standpoint, SLDE offers an unusually asymmetric setup for a profitable insurer: at $25.94 it trades at 4.10x trailing earnings and roughly 6.7x the $3.88 consensus forward EPS, versus the 8–12x EV/EBITDA typical of specialty P&C peers, while growing revenue 35.89% YoY at a 38.29% net margin. The base case (55% probability) targets $26–$32, the bull case (25%) $34–$38, and the bear case (20%) $16–$20 — a distribution skewed modestly to the upside with a fat left tail. The biggest downside risk is a Florida hurricane landfall coinciding with reinsurance repricing, which could take the stock to its June 2026 low of $16.03, roughly -38%. It is a good buy for risk-tolerant investors who can size it as a satellite position and stomach a -35% to -40% adverse scenario; it is not appropriate for conservative or income-oriented portfolios, particularly with no dividend (payout ratio 0) and only ~17 months of public trading history.